Febrile Neutropenia
📧 Sign up to get email alerts when something new happens for Febrile Neutropenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-03-21FDA Approved: FULPHILA — Supplemental Application (Biocon Biologics Inc.)
FDA supplemental approval for Fulphila (pegfilgrastim-jmdb) by Biocon Biologics Inc. to update/expand the approved labeling for this biosimi…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia [NA]
This is a completed multi-center non-inferiority trial comparing high versus low temperature thresholds to define fever in pediatric cancer …
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia
Non-interventional study evaluating home administration of the filgrastim biosimilar Nivestim for primary prophylaxis of chemotherapy-induce…
-
CLINICAL_TRIALS withdrawal · 2019-02-01Clinical Trial Update: Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study [Phase 3]
A Phase 3 trial evaluating early stoppage versus continuation of antimicrobial therapy in low-risk pediatric cancer patients with febrile ne…
-
CLINICAL_TRIALS research · 2019-01-17Clinical Trial Update: Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients [Phase 2]
Phase 2 pediatric trial assessing whether synbiotics can prevent febrile neutropenia in children with cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients [Phase 4]
Phase 4 trial update evaluating G-CSF for prevention of febrile neutropenia in gynecologic cancer patients undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia [Phase 1]
A Phase 1 clinical trial updating on prolonged versus standard infusion of cefepime hydrochloride for treating febrile neutropenia in adults…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases [Phase 3]
Phase 3 trial compared ciprofloxacin to cefepime in febrile neutropenic patients with hematologic diseases. The study has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay
A completed clinical trial from Karius evaluated a sequencing-based infectious disease diagnostic assay to determine the etiology of febrile…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever
This is a completed post-marketing surveillance trial evaluating Lipo-AB (Amphotericin B) in patients with febrile neutropenia.
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia [Phase 2]
Phase 2 clinical trial assessing whether oral magnesium supplementation can reduce febrile neutropenia. The snippet indicates the status as …
-
FDA approval · 2017-12-09FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)
FDA approves a supplemental application for NEULASTA (pegfilgrastim) filed by Amgen, Inc.
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia [Phase 4]
Phase 4 study evaluating whether shortening the duration of antibiotic therapy in hematologic patients with fever and neutropenia is as safe…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer [Phase 2]
Phase 2 trial comparing ceftazidime-avibactam to standard of care in febrile neutropenic adults with cancer was terminated; results were pos…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) [Phase 2]
Phase 2 trial comparing MK0991 to Amphotericin B for empirical therapy in febrile neutropenic pediatric patients has completed.
-
FDA approval · 2017-02-17FDA Approved: ZARXIO — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for ZARXIO (filgrastim-sndz) filed by Sandoz Inc.
-
CLINICAL_TRIALS research · 2017-01-26Clinical Trial Update: Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma
This is an update on a multicenter prospective registry study of diffuse large B-cell lymphoma; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Early Antibiotic Discontinuation in FUO
This completed trial assesses whether antibiotics can be discontinued early in febrile neutropenia associated with hematologic malignancies.
-
CLINICAL_TRIALS research · 2016-08-01Clinical Trial Update: Profiling Neutrophil Counts in Patients on Chemotherapy
A clinical trial update profiling neutrophil counts in patients receiving chemotherapy. The current status and results are not provided.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Study of Danggui Buxue Decoction in Preventing Neutropenia [Phase 2]
Phase 2 clinical trial of Danggui Buxue Decoction for preventing Grade 3/4 neutropenia and febrile neutropenia completed.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
This clinical trial update reports on the tolerance of Nivestim (filgrastim) in patients treated with highly toxic chemotherapeutic regimens…
-
CLINICAL_TRIALS research · 2015-06-04Clinical Trial Update: Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia [Phase 4]
Phase 4 clinical trial update evaluating whether short-duration versus prolonged antibiotic therapy is as effective as longer courses in hos…
-
CLINICAL_TRIALS research · 2014-12-24Clinical Trial Update: Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
Completed Amgen-sponsored trial (NCT01813721) evaluating how physicians assess the risk of febrile neutropenia in patients undergoing chemot…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases [Phase 2]
A Phase 2 trial update comparing micafungin to intravenous itraconazole as empirical antifungal therapy in febrile neutropenia patients with…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia [Phase 4]
Phase 4 clinical trial comparing the pharmacodynamics of imipenem in patients with febrile neutropenia.